Back to Search Start Over

Multilevel factors are associated with immunosuppressant nonadherence in heart transplant recipients: The international BRIGHTstudy

Authors :
Denhaerynck, Kris
Berben, Lut
Dobbels, Fabienne
Russell, Cynthia L.
Crespo‐Leiro, Marisa G.
Poncelet, Alain Jean
De Geest, Sabina
Crespo‐Leiro, Maria G.
Cupples, Sandra
De Simone, Paolo
Groenewoud, Albert
Kugler, Christiane
Ohler, Linda
Van Cleemput, Johan
Sebbag, Laurent
Michel, Magali
Bernard, Andrée
Doesch, Andreas
Livi, Ugolino
Manfredini, Valentina
Brossa‐Loidi, Vicens
Segovia‐Cubero, Javier
Almenar‐Bonet, Luis
Saint‐Gerons, Carmen Segura
Mohacsi, Paul
Horvath, Eva
Riotto, Cheryl
Parry, Gareth
Firouzi, Ashi
Kozuszko, Stella
Haddad, Haissam
Kaan, Annemarie
Fisher, Grant
Miller, Tara
Flattery, Maureen
Ludrosky, Kristin
Coleman, Bernice
Trammell, Jacqueline
St. Clair, Katherine
Kao, Andrew
Molina, Maria
Canales, Karyn Ryan
Almeida, Samira Scalso
Ayoub, Andrea Cotait
Barone, Fernanda
Harkess, Michelle
Maddicks‐Law, Joanne
Source :
American Journal of Transplantation; June 2018, Vol. 18 Issue: 6 p1447-1460, 14p
Publication Year :
2018

Abstract

Factors at the level of family/healthcare worker, organization, and system are neglected in medication nonadherence research in heart transplantation (HTx). The 4‐continent, 11‐country cross‐sectional Building Research Initiative Group: Chronic Illness Management and Adherence in Transplantation (BRIGHT) study used multistaged sampling to examine 36 HTx centers, including 36 HTx directors, 100 clinicians, and 1397 patients. Nonadherence to immunosuppressants—defined as any deviation in taking or timing adherence and/or dose reduction—was assessed using the Basel Assessment of Adherence to Immunosuppressive Medications Scale©(BAASIS©) interview. Guided by the Integrative Model of Behavioral Prediction and Bronfenbrenner's ecological model, we analyzed factors at these multiple levels using sequential logistic regression analysis (6 blocks). The nonadherence prevalence was 34.1%. Six multilevel factors were associated independently (either positively or negatively) with nonadherence: patient level: barriers to taking immunosuppressants (odds ratio [OR]: 11.48); smoking (OR: 2.19); family/healthcare provider level: frequency of having someone to help patients read health‐related materials (OR: 0.85); organization level: clinicians reporting nonadherent patients were targeted with adherence interventions (OR: 0.66); pickup of medications at physician's office (OR: 2.31); and policy level: monthly out‐of‐pocket costs for medication (OR: 1.16). Factors associated with nonadherence are evident at multiple levels. Improving medication nonadherence requires addressing not only the patient, but also family/healthcare provider, organization, and policy levels. Multilevel factors, such as relation to the patient, healthcare provider, transplant center, and healthcare system, are associated with immunosuppressive drug nonadherence in heart transplant recipients, indicating a need for multilevel interventions to address nonadherence.

Details

Language :
English
ISSN :
16006135 and 16006143
Volume :
18
Issue :
6
Database :
Supplemental Index
Journal :
American Journal of Transplantation
Publication Type :
Periodical
Accession number :
ejs45722877
Full Text :
https://doi.org/10.1111/ajt.14611